Avita Medical | 1811094D - Ebit





Ebit Perubahan Tanggal
Accuray USD 11.38M 12.71M 2024-09
Celltrion KRW 12.08B 288.96B 2025-12
Clinuvel Pharmaceuticals AUD 13.51M 15.95M 2025-12
Cochlear AUD 261.1M 13.9M 2025-12
CSL USD 2.64B 116M 2025-12
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 8.14B 420M 2026-03
Kangmei Pharma CNY -12.72M 13.97M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Mayne Pharma AUD -16.2M 13.2M 2024-06
Medical Developments International AUD -36K 12.96M 2025-12
Nanosonics AUD 9.12M 422K 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pacific Edge NZD -16.94M 2.46M 2026-06
Paradigm Biopharmaceuticals AUD -21.57M 11.26M 2025-12
Pharma Mar EUR 622K 42.99M 2026-03
Polynovo AUD 2.06M 1.18M 2025-12
PYC Therapeutics AUD -22.59M 3.25M 2025-12
Qiagen NV USD 121.88M 19.18M 2025-12
Ramsay Health Care AUD 541.1M 20.7M 2025-12
ResMed USD 497.6M 35.25M 2025-12
Sartorius EUR 160.7M 94.1M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Telix Pharmaceuticals AUD 8.04M 3.21M 2025-12
Tilray USD -20.01M 9.34M 2025-09
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 837.81M 336.48M 2026-03